Understand the source comparison
Adamax Peptide 10mg: Research Application Comparison
Understanding how adamax peptide 10mg compares to other metabolic research compounds helps researchers select the appropriate tool for specific pathway investigations. The table below contrasts adamax with structurally and functionally related peptides across
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Understanding how adamax peptide 10mg compares to other metabolic research compounds helps researchers select the appropriate tool for specific pathway investigations. The table below contrasts adamax with structurally and functionally related peptides across key research parameters.
- Adamax Peptide 10mg
- AMPK activation, acetyl-CoA carboxylase inhibition
- 4–6 hours
- 2–8°C, use within 28 days
- 1–10 μM in cell culture, 0.5–2 mg/kg in vivo
- Acute metabolic shift studies, substrate utilisation protocols, insulin sensitivity assays
- AOD9604
- Lipolysis via β3-adrenergic pathway, no insulin effect
- 2–3 hours
- 2–8°C, use within 21 days
- 0.5–5 μM in vitro, 0.25–1 mg/kg in vivo
- Adipocyte lipolysis studies without glucose confounding, isolated fat oxidation measurements
- 5 Amino 1MQ
- NNMT inhibition, NAD+ elevation
- 6–8 hours
- 5–20 μM in cell culture, 1–5 mg/kg in vivo
- NAD+ metabolism research, sirtuin activation studies, mitochondrial function protocols
- Tesofensine
- Triple monoamine reuptake inhibition (serotonin, norepinephrine, dopamine)
- 8–10 hours (longer than peptides)
- Room temp stable in solution
- 0.1–1 μM in vitro, 0.25–2 mg/kg in vivo
- Appetite signaling research, central nervous system metabolic regulation, long-duration energy expenditure studies